BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21929341)

  • 1. Impact of oral chronic administration of sildenafil in children and young adults after the Fontan operation.
    Ciliberti P; Giardini A
    Future Cardiol; 2011 Sep; 7(5):609-12. PubMed ID: 21929341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial.
    Goldberg DJ; French B; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J
    Circulation; 2011 Mar; 123(11):1185-93. PubMed ID: 21382896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
    Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
    Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of pulmonary vascular resistance as a target for therapeutic interventions in Fontan patients: focus on phosphodiesterase inhibitors.
    Ciliberti P; Schulze-Neick I; Giardini A
    Future Cardiol; 2012 Mar; 8(2):271-84. PubMed ID: 22413985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients.
    Butts RJ; Chowdhury SM; Baker GH; Bandisode V; Savage AJ; Atz AM
    Pediatr Cardiol; 2016 Jan; 37(1):184-91. PubMed ID: 26409473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
    Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension.
    Barst RJ; Ivy DD; Gaitan G; Szatmari A; Rudzinski A; Garcia AE; Sastry BK; Pulido T; Layton GR; Serdarevic-Pehar M; Wessel DL
    Circulation; 2012 Jan; 125(2):324-34. PubMed ID: 22128226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; CalabrĂ² R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.
    Giardini A; Balducci A; Specchia S; Gargiulo G; Bonvicini M; Picchio FM
    Eur Heart J; 2008 Jul; 29(13):1681-7. PubMed ID: 18534975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
    Guazzi M; Vicenzi M; Arena R
    Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is chronic sildenafil therapy safe and clinically beneficial in patients with systolic heart failure?
    Amin A; Mahmoudi E; Navid H; Chitsazan M
    Congest Heart Fail; 2013; 19(2):99-103. PubMed ID: 23241003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vitamin C on endothelial function and exercise capacity in patients with a Fontan circulation.
    Goldstein BH; Sandelin AM; Golbus JR; Warnke N; Gooding L; King KK; Donohue JE; Yu S; Gurney JG; Goldberg CS; Rocchini AP; Charpie JR
    Congenit Heart Dis; 2012; 7(3):226-34. PubMed ID: 22176653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
    Bharani A; Mathew V; Sahu A; Lunia B
    Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.
    Guazzi M; Vicenzi M; Arena R; Guazzi MD
    Circ Heart Fail; 2011 Jan; 4(1):8-17. PubMed ID: 21036891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic characteristics of cyanotic adults with single-ventricle physiology without Fontan completion.
    Saab FG; Aboulhosn JA
    Congenit Heart Dis; 2013; 8(2):124-30. PubMed ID: 22891795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of systemic venous return, pulmonary vascular resistance, and diastolic dysfunction to exercise capacity in patients with single ventricle receiving fontan palliation.
    Goldstein BH; Connor CE; Gooding L; Rocchini AP
    Am J Cardiol; 2010 Apr; 105(8):1169-75. PubMed ID: 20381672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional capacity following univentricular repair--midterm outcome.
    Sen S; Bandyopadhyay B; Eriksson P; Chattopadhyay A
    Congenit Heart Dis; 2012; 7(5):423-32. PubMed ID: 22471644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.